Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Evaluation of the Effect of Pentoxifylline on the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

NCT05189535 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05189535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05189535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Evaluation of the Effect of Pentoxifylline on the Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"
Lead sponsor
Ain Shams University
Phase
Phase 2/3
Overall status
Completed
Start date
October 3, 2021
Completion date
September 28, 2023
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, peripheral neuropathy